【摘要】 为评价血脂康胶囊对颈动脉粥样硬化的影响 ,随机将合并颈动脉粥样硬化的高脂血症患者 30例分为血脂康组与洛伐他汀对照组 ,各 15例 ,用颈动脉彩色超声多普勒检测 ,记录颈动脉内膜 -中膜厚度(IMT) ,治疗 6个月后复查。结果显示 ,两组治疗后IMT均显著下降 ,与治疗前比较P <0 .0 5 ;组间比较无显著差异 (P >0 .0 5 )。表明血脂康与洛伐他汀均有减轻颈动脉粥样硬化的作用更多还原

【Abstract】 To evaluate the effect of Xuezhikang on atherosclerosis plaque in carotid artery. 30 patients with both hyperlipidemia and carotid artery atherosclerosis were divided randomly into Xuezhikang group(15 cases) and Lovastatin control group(15 cases). The carotid artery intima-media thickness(IMT) were assessed with Doppler ultrasonography before and after treatment for 6 months. IMT in both group decreased remarkably, and there was significant difference before and after treatment(P<0.05). But there was no difference between the two groups(P>0.05). The results show that both Xuezhikang and Lovastatin has the effect on alleviating carotid atherosclerosis plaque.更多还原